Diapin Therapeutics

Pre-clinical

Cambridge, United StatesFounded 2018diapin.com

Diapin was founded by Dr. Yuqing (Eugene) Chen, M.D., Ph.D., based on technology disclosed to the University of Michigan from Dr. Chen’s laboratory. Diapin Therapeutics is a spin out company from the University of Michigan. Research at Diapin has been funded by grants and Beijing SL Pharmaceuticals LTD (Beijing SL). (See Investors and Collaborators).

Founded

2018

Focus

RNA & Gene Therapy

About

Diapin was founded by Dr. Yuqing (Eugene) Chen, M.D., Ph.D., based on technology disclosed to the University of Michigan from Dr. Chen’s laboratory. Diapin Therapeutics is a spin out company from the University of Michigan. Research at Diapin has been funded by grants and Beijing SL Pharmaceuticals LTD (Beijing SL). (See Investors and Collaborators).

Company Info

TypePrivate

Founded2018

LocationCambridge, United States

StagePre-clinical

Contact

Sectors

RNA Therapeutics (non-mRNA)

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.